Sign In
Buy BETRF
$0.138
-0.0026 (-1.86%)
At Close: Jul 13, 2026
Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained as optional fut
BetterLife Engages Nucro-Technics to Complete the last GLP Toxicology Study of BETR-001 Required by the FDA for IND and Phase 1
08:00am, Monday, 06'th Jul 2026
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") announces it has entered into an agreemen
BetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1
08:00am, Thursday, 25'th Jun 2026
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") announces it has entered into an agreem
BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing
08:00am, Monday, 22'nd Jun 2026
Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") today announced
BetterLife Pharma Announces Appointment of Doug Drysdale as Executive Chairman and Director
08:00am, Wednesday, 13'th May 2026
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the
BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco
08:00am, Tuesday, 06'th Jan 2026
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biopharmaceutical compan
BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen
08:00am, Thursday, 04'th Dec 2025
VANCOUVER, British Columbia – TheNewswire - December 4, 2025 - BetterLife Pharma Inc. (“BetterLife” or the “Compa ny”) ( CSE: BETR / OTCQB: BETRF / FRA: NPAU ) , an emerging biotech company,
BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor
08:00am, Tuesday, 25'th Nov 2025
VANCOUVER, British Columbia, November 25, 2025 – TheNewswire - BetterLife Pharma Inc. (“BetterLife” or the “Compa ny”) ( CSE: BETR / OTCQB: BETRF / FRA: NPAU ) , an emerging biotech company,
Head-To-Head Analysis: Vivos Therapeutics (NASDAQ:VVOS) vs. BetterLife Pharma (OTCMKTS:BETRF)
01:53am, Sunday, 26'th Oct 2025
BetterLife Pharma (OTCMKTS:BETRF - Get Free Report) and Vivos Therapeutics (NASDAQ: VVOS - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast
USPTO Files ISSUE NOTIFICATION for BetterLife's BETR-001 Composition of Matter Patent
08:00am, Wednesday, 18'th Jun 2025
VANCOUVER, British Columbia, June 18, 2025 – TheNewswire - BetterLife Pharma Inc. (“BetterLife” or the “Compa ny”) ( CSE: BETR / OTCQB : BETRF / FRA: NPAU ) , an emerging biotech company foc
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
08:00am, Wednesday, 14'th May 2025
VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focuse
BetterLife Announces Debt Settlements
04:38pm, Tuesday, 06'th May 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focuse
BetterLife Pharma Appoints Corporate Advisor
08:00am, Thursday, 03'rd Apr 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has
BetterLife Pharma Appoints New Director
08:00am, Monday, 31'st Mar 2025
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is
BetterLife Announces Debt Conversions
08:00am, Monday, 10'th Mar 2025
VANCOUVER, British Columbia, March 10, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focu
